MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-02-0003212
Puerto Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.22 Cr
▼ 10% YoY
Net loss · FY 2025
₹5.99 Cr
Net margin -20.5%
EBITDA · FY 2025
₹5.59 Cr
EBITDA margin 19.1%
Authorised capital
₹22 Cr
Registered with MCA
Paid-up capital
₹20.03 Cr
Issued & subscribed
Open charges
₹71.36 Cr
Satisfied ₹28.19 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
144
Provident fund records
About Puerto Life Sciences Private Limited
Data last updated:
Puerto Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36990DL2018PTC340100. Its GSTIN is 07AAKCP1211D1ZY (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹20.03 Cr. It is led by directors including Vardaan Sharma (Managing Director) and Anju Jolly.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 24 G/F C S C Saini Enclave, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.22 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹5.99 Cr (net margin -20.5%) and EBITDA of ₹5.59 Cr (EBITDA margin 19.1%). Revenue has grown at a compounded annual rate (CAGR) of 655% over three years.
The company has about 144 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹71.36 Cr and satisfied charges of ₹28.19 Cr on record. Court records list 17 cases involving the company, including 7 filed by the company and 9 filed against it; 7 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Pesino Pharmaceuticals Private Limited with revenue of ₹29.51 Cr.
Puerto Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0003212). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website puertolifesciences.com.
Company Details of Puerto Life Sciences Private Limited
CIN U36990DL2018PTC340100
Registration Number 340100
Incorporation Date 04 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-02-0003212
Recognitions & Rankings of Puerto Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No – 24 G/F C S C Saini Enclave, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Puerto Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Puerto Life Sciences Private Limited
The main business activity of Puerto Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Puerto Life Sciences Private Limited FY 2025 filings available
Puerto Life Sciences Private Limited reported revenue of ₹29.22 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹29.22 Cr ▼ 10%
Net loss · FY 2025
₹5.99 Cr margin -20.5%
EBITDA · FY 2025
₹5.59 Cr margin 19.1%
Compounded Annual Growth Rate (CAGR) of Puerto Life Sciences Private Limited
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 655%
EBITDA CAGR growth
3 years · compounded
▲ 87%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 655%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Puerto Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.59 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹5.99 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Puerto Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -20.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Puerto Life Sciences are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Puerto Life Sciences Private Limited
Puerto Life Sciences has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Jolly Also directs: Nitvik Estates and Spaces LLP | Director | 04 Oct 2018 | 8 Years 0 Months | Current |
| Vardaan Sharma Also directs: Arm Infraestate Private Limited, Ashajyoti Exports Private Limited, Neelkanth Pharma Logistics Private Limited and 3 more | Managing Director | 05 Dec 2024 | 1 Years 10 Months | Current |
| Veerinder Pal Singh Also directs: Neelkanth Pharma Logistics Private Limited, Saviour Wellness Private Limited, Levikas Enterprises Private Limited and 1 more | Director | 25 Oct 2018 | 7 Years 11 Months | Current |
| Pramod Kumar Sharma Also directs: Shree Shyam Speciality Chemicals Private Limited, KSJN Chemicals Private Limited, SSND Medimart Private Limited and 5 more | Director | 17 Jul 2019 | 7 Years 3 Months | Current |
Peer Comparison of Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pesino Pharmaceuticals Private Limited | ₹29.51 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Mumbai, Maharashtra, India |
| Medion Biotech Private Limited | ₹29.5 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Delhi, India |
| FTF Pharma Private Limited | ₹29.49 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Ahmedabad, Gujarat, India |
| Kantil Pharmaceuticals Private Limited | ₹29.42 Cr (FY 2024) | •••• | •••• | 924.0% | •••• | Delhi, India |
| Rapross Pharmaceuticals Private Limited | ₹29.39 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Puerto Life Sciences Private Limited this company | ₹29.22 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Delhi, India |
| Saf Fermion Ltd. | ₹29.2 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Atomlife Healthcare and Research Private Limited | ₹29.2 Cr (FY 2024) | •••• | •••• | 46.0% | •••• | Thiruvananthapuram, Kerala, India |
| Universal Pharmaceuticals Private Limited | ₹29.2 Cr (FY 2025) | •••• | •••• | 189.0% | •••• | Chennai, Tamil Nadu, India |
| Avigna Chemitech Private Limited | ₹29.16 Cr (FY 2022) | •••• | •••• | -16.0% | •••• | Bangalore, Karnataka, India |
| Sonia Laboratory Private Limited | ₹29.16 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Puerto Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited is audited by P V A R & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P V A R & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Puerto Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Puerto Life Sciences Private Limited
Open charges
₹71.36 Cr
Satisfied charges
₹28.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2021 | Hdfc Bank Limited | ₹71.36 Cr | Open |
| 07 Dec 2021 | The South Indian Bank Limited | ₹2 Cr | Satisfied |
| 24 Mar 2021 | The South Indian Bank Limited | ₹1.19 Cr | Satisfied |
| 12 Feb 2020 | The South Indian Bank Limited | ₹25 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020.
Total deals
3
Rights issues
2
Secondary share transfer
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Rights issue | ₹8.4 Cr | Investors: 3 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2019 | Rights issue | ₹3.9 Cr | Investors: 4 individuals |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited has 17 court cases on record: 7 filed by Puerto Life Sciences, 9 filed against it, 1 where it is another party. 7 cases are pending and 10 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
17
Filed by the company
7
Filed against the company
9
Pending
7
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 6 | 4 |
| District courts | 3 | 2 | 3 |
| NCLAT | 1 | 1 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against Jaipur Vidyut Vitran Nigam Limited | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Jaipur Vidyut Vitran Nigam Limited | Pending |
| High Court of Delhi | Court case (O.M.P. (T) (COMM.)) | Filed against the company by Sterimax India Private Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against Sterimax India Private Limited | Disposed |
| High Court of Delhi | Court case (O.M.P. (COMM)) | Filed by the company against an individual | Pending |
Premium access
Full case history
All 17 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited has a workforce of 144 employees as of Apr 08, 2024.
Employee count
144
Active EPFO establishments
1
Employee growth
16.13%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Puerto Life Sciences Private Limited
Puerto Life Sciences Private Limited has 12 board changes on record since 2018: 4 appointments and 8 cessations. The latest: Vardaan Sharma was appointed as Managing Director on 05 Dec 2024.
AGM
Puerto Life Sciences Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 71.36 Cr registered on 30 Nov 2021 with Charge ID 100518737 was modified on 16 Jun 2025.
Filing
Puerto Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 07 Dec 2021 via Charge ID 100517160 with The South Indian Bank Limited was fully satisfied on 28 Jan 2025.
Charges
A charge registered on 24 Mar 2021 via Charge ID 100438225 with The South Indian Bank Limited was fully satisfied on 28 Jan 2025.
Appointed
Vardaan Sharma was appointed as Managing Director.
Ceased
Nilanchal Pradhan ceased to be Company Secretary.
Ceased
Ayan Sharma ceased to be Additional Director.
Ceased
Nisha Walia ceased to be Director.
Ceased
Abhishek Jain ceased to be Director.
Charges
A charge registered on 12 Feb 2020 via Charge ID 100328084 with The South Indian Bank Limited was fully satisfied on 18 Dec 2021.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100517160 was registered on 07 Dec 2021.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Puerto Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Puerto Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Puerto Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Puerto Life Sciences Private Limited
Puerto Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP1211D1ZY | Delhi | Active | 26 Oct 2018 |
| 08AAKCP1211D1ZW | Rajasthan | Active | 21 Jan 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Puerto Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Puerto Life Sciences Private Limited
Puerto Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2018 (8+ years old) and is registered under CIN U36990DL2018PTC340100.
Puerto Life Sciences reported revenue of ₹29.22 Cr for FY 2025 (down 10% YoY).
Puerto Life Sciences has 4 current directors:
- Vardaan Sharma - Managing Director
- Anju Jolly - Director
- Veerinder Pal Singh - Director
- Pramod Kumar Sharma - Director
Puerto Life Sciences reported a net loss of ₹5.99 Cr (net margin -20.5%) and EBITDA of ₹5.59 Cr (EBITDA margin 19.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Puerto Life Sciences is 655% over three years. In the latest year (FY 2025) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Puerto Life Sciences is 07AAKCP1211D1ZY, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAKCP1211D1ZW (Rajasthan).
The CIN (Corporate Identification Number) of Puerto Life Sciences is U36990DL2018PTC340100. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Puerto Life Sciences has 17 court cases on record: 7 filed by the company and 9 filed against it. 7 are pending. Most are in the high courts.
Puerto Life Sciences was incorporated on 04 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Puerto Life Sciences has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020.
The peers of Puerto Life Sciences by revenue are Pesino Pharmaceuticals Private Limited, Medion Biotech Private Limited, FTF Pharma Private Limited, Kantil Pharmaceuticals Private Limited, Rapross Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).